<
 
 
 
 
×
>
hide
You are viewing a Web site, archived on 00:26:31 Dec 06, 2014. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.

Markup of H.R. 4299, "Improving Regulatory Transparency for New Medical Therapies Act," H.R. 4709, "Ensuring Patient Access and Effective Drug Enforcement Act," and H.R. 4631, "Combating Autism Reauthorization Act," Subcommittee on Health (May 28, 2014)

Subcommittee on Health (113th Congress)
May 28, 2014
2123 Rayburn House Office Building

The Subcommittee on Health held a markup on Wednesday, May 28, 2014, at 2:00 p.m. in 2123 Rayburn House Office Building.  The Subcommittee considered the following bills:

  • H.R. 4299, “Improving Regulatory Transparency for New Medical Therapies Act”;
  • H.R. 4709, “Ensuring Patient Access and Effective Drug Enforcement Act”; and,
  • H.R. 4631, “Combating Autism Reauthorization Act of 2014.”
     

Documents

Memorandum from Ranking Member Henry A. Waxman to Democratic Members of the Subcommittee on Health

Transcript

 

H.R. 4299, “Improving Regulatory Transparency for New Medical Therapies Act,” favorably forwarded by voice vote. 

H.R. 4709, “Ensuring Patient Access and Effective Drug Enforcement Act," favorably forwarded by voice vote.

H.R. 4631, “Combating Autism Reauthorization Act of 2014,” favorably forwarded, as amended, by voice vote. 

Amendment by Rep. Pitts, passed by voice vote.

 

Webcast

113th Congress